Analyst Research Report Snapshot

Title:

Result Note – Kossan (ADD, maintain) - Flat margins hamper 1HFY12 earnings growth

Price:

$35.00

Provider:

Affin Investment Bank

Date:

09 Oct 2012

Pages:

4

Type:

AcrobatPDF

Companies referenced:

KRIB.KL

Available for Immediate Download
Summary:

Below expectations Kossan reported 1HFY12 revenue of RM594.2m (+11.7% yoy), driven by: 1) higher volume sales and revenue growth of +11.2% yoy in the rubber gloves division, and; 2) stronger revenue contribution of +4.8% yoy in the technical rubber products (TRP) division. Average latex price in 1HFY12 declined by -26.1% yoy – consequently, the lower raw material costs, as well as improved production efficiency helped lift PBT margin in the TRP division by +3.1%-points yoy. However, PBT margin in the rubber gloves division fell by -0.4%-points yoy, which we suspect may be due to stronger price competition within the nitrile glove segment. Note that after Hartalega, Kossan is the most exposed to the nitrile glove segment (c. 40% of total gloves production). Overall, Kossan’s 1HFY12 EBITDA margin was relatively flat at 14.3% vs. 14.5% in 1HFY11. Factoring in a higher effective tax rate (22.1% vs. 18.1% in 1HFY11), 1HFY12 net profit grew by a weaker +3.8% yoy to RM45.6m. Results were below expectations, accounting for only 42% and 40% of our and consensus expectations. The variance was largely due to lower-than-expected revenue and margins from stronger price competition.

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.